Pediatric ED Visits Before and During the COVID-19 Pandemic

Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — United States, January 2019–January 2022

United States, January 2019-January 2022

Lakshmi Radhakrishnan, MPH; Kelly Carey, MPH; Kathleen P. Hartnett, PhD; Aaron Kite-Powell, MS; Marissa Zwald, PhD; Kayla N. Anderson, PhD; Rebecca T. Leeb, PhD; Kristin M. Holland, PhD; Abigail Gates, MSPH; Jourdan DeVies, MS; Amanda R. Smith, PhD; Katharina L. van Santen, MSPH; Sophia Crossen, MS; Michael Sheppard, MS; Samantha Wotiz, MPH; Amelia G. Johnson, DrPH; Amber Winn, MPH; Hannah L. Kirking, MD; Rashon I. Lane, PhD, MA; Rashid Njai, PhD; Loren Rodgers, PhD; Craig W. Thomas, PhD; Karl Soetebier, MAPW; Jennifer Adjemian, PhD

Disclosures

Morbidity and Mortality Weekly Report. 2022;71(8):313-318. 

In This Article

Abstract and Introduction

Introduction

Emergency departments (EDs) in the United States remain a frontline resource for pediatric health care emergencies during the COVID-19 pandemic; however, patterns of health-seeking behavior have changed during the pandemic.[1,2] CDC examined changes in U.S. ED visit trends to assess the continued impact of the pandemic on visits among children and adolescents aged 0–17 years (pediatric ED visits). Compared with 2019, pediatric ED visits declined by 51% during 2020, 22% during 2021, and 23% during January 2022. Although visits for non–COVID-19 respiratory illnesses mostly declined, the proportion of visits for some respiratory conditions increased during January 2022 compared with 2019. Weekly number and proportion of ED visits increased for certain types of injuries (e.g., drug poisonings, self-harm, and firearm injuries) and some chronic diseases, with variation by pandemic year and age group. Visits related to behavioral concerns increased across pandemic years, particularly among older children and adolescents. Health care providers and families should remain vigilant for potential indirect impacts of the COVID-19 pandemic, including health conditions resulting from delayed care, and increasing emotional distress and behavioral health concerns among children and adolescents.

CDC assessed data from the National Syndromic Surveillance Program (NSSP)* for three surveillance periods: March 15, 2020–January 2, 2021 (2020), January 3, 2021–January 1, 2022 (2021), and January 2, 2022–January 29, 2022 (January 2022), and compared them with corresponding weeks in 2019 from health care facilities consistently† reporting data during 2019– January 2022. Data were evaluated by total visits among children and adolescents aged 0–17 years, and by three age groups (0–4, 5–11, and 12–17 years), and visit diagnoses

To continue reading this article ...
or
Continue reading your article with a Medscape account

Join the Top Medical Resource for Physicians Today. Free Membership!

*NSSP is a collaboration among CDC, local, and state health departments, and federal, academic, and private sector partners. https://www.cdc.gov/nssp/index.html
To reduce artifactual impact from changes in reporting patterns, analyses were restricted to facilities with a coefficient of variation ≤40 and average weekly informative discharge diagnosis ≥75% complete with consistent discharge diagnosis code formatting throughout 2019–2022. Visits from 1,674 facilities from 41 states were eligible to be included in the study. All facilities from three counties in California (El Dorado, Plumas, and Yosemite), the District of Columbia, Florida, Guam, Hawaii, Maryland, Nebraska, Ohio, Oklahoma, South Dakota, Virginia, Wyoming, and one facility from Washington were excluded because they do not meet one of the inclusion criteria.
§A full list of categories and corresponding codes is available at the HCUP website: https://www.hcup-us.ahrq.gov/toolssoftware/ccsr/dxccsr.jsp (Accessed January 14, 2022).
To assess greatest increases and decreases in mean weekly visits, no filtering on visit count or relative standard error was applied. VRs were calculated as the proportion of all ED visits in each diagnostic category during the pandemic surveillance period, divided by the proportion of all ED visits in that category during the comparison period. Ninety-five percent CIs that excluded 1 were considered statistically significant. To maintain practical relevance of results, VRs were suppressed if there were <100 visits, the difference in visit counts between periods was <100, or the relative standard error was >30%. Ratios of not applicable (N/A) do not meet at least one of those criteria.
**45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.

Recommendations

processing....